Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrawound vancomycin powder in spinal fusion surgery to reduce surgical site infections
2014-002096-29Phase 4Completed
- Sponsor
- Orthopedic Hospital Speising
- Start
- Jun 2015
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of vancomycin in surgical site infection (SSI) (2 arms), sponsored by Orthopedic Hospital Speising. Primary endpoint: Rate of surgical site infections according to CDC definitions. Started Jun 2015; status: completed.
02
Drugs
vancomycin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on 2014-002096-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002096-29.